Cusabio Vaccinia virus Recombinant

Shortly after the World Health Assembly resolution recommending the cessation of smallpox vaccination, proposals were made to use recombinant vaccinia viruses for immunization against other infectious agents. 161, 162 The idea was to stably insert one or more genes from other pathogens into the vaccinia virus genome while maintaining the latter’s infectivity. Furthermore, the high capacity of the vaccinia virus recombinant for foreign DNA raised the possibility of polyvalent vaccines against multiple diseases.

In principle, recombinant vaccinia viruses would have many of the properties of live attenuated virus vaccines and would naturally present antigens to stimulate humoral immunity to native protein conformation as well as cell-mediated immunity. Such vaccines could also retain the familiar advantages of the smallpox vaccine: heat stability, low cost, ease of administration, and a scar as visible proof of vaccination. Although recombinant vaccinia viruses are still being investigated for human and veterinary vaccination, their great value for vaccine research has been widely recognized.

Purity: greater than 85% as determined by SDS-PAGE.

Destination names: CTSK

Uniprot No.: P18378

Research Area: Others

Alternative names: (K2 protein)

Species: Vaccinia Virus (Western Reserve strain) (VACV) (Vaccinia virus (WR strain))

Source: Baculovirus

Expression Region: 1-88aa

Mole Weight: 11.6 kDa

Protein Length: Total length

Tag Information: N-terminal 6xHis-tagged

Form: Liquid or Lyophilized Powder

Note: We will preferably ship the format we have in stock, however, if you have any special requirements for the format, please remark your requirement when placing the order, we will prepare according to your demand.

Buffer

If the dosage form is liquid, the default storage buffer is Tris/PBS based buffer, 5%-50% glycerol. If the administration form is a lyophilized powder, the buffer before lyophilization is a Tris/PBS-based buffer, 6% trehalose, pH 8.0.

Reconstitution

We recommend that this vial be briefly centrifuged before opening to bring the contents to the bottom. Reconstitute protein in sterile deionized water at a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and an aliquot for long-term storage at -20°C/-80°C. Our final default glycerol concentration is 50%. Customers could use it for reference.

Storage Conditions

Store at -20°C/-80°C upon receipt, need to be aliquoted for multiple uses. Avoid repeated cycles of freezing and thawing.

Shelf life

Shelf life is related to many factors, storage condition, buffer ingredients, storage temperature and the stability of the protein itself. Generally, the shelf life of the liquid form is 6 months at -20°C/-80°C. The shelf life of the lyophilized form is 12 months at -20°C/-80°C.

Delivery time

The delivery time may differ depending on the way or location of purchase, consult your local distributors for the specific delivery time.

Notes: Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.

Vaccinia virus as a tool for vaccine research

Recombinant vaccinia viruses provide a powerful means of dissecting the immune responses of humans and experimental animals to individual gene products of infectious agents. Only a few examples can be mentioned here. Therefore, recombinant vaccinia viruses were used to demonstrate that influenza virus HA and NP proteins induced subtype-specific and cross-reactive cytotoxic T-cell responses, respectively. Evidence for human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T cells in patients with acquired immunodeficiency syndrome (AIDS) was first obtained by using recombinant vaccinia viruses expressing envelope or internal proteins to prepare target cells.

Indeed, recombinant vaccinia viruses have become an important tool for cellular immunologists. Because proteins expressed in mammalian cells by recombinant vaccinia viruses are normally folded, processed, and transported, they can be used to induce or bind antibodies that recognize conformational epitopes. The wide host range of vaccinia viruses makes it possible to determine protective immune responses against infectious agents in a variety of experimental animals, from rodents to primates.

For example, the F glycoprotein is more important for inducing protection against respiratory syncytial virus, while the HN protein is better for parainfluenza virus type 3 and type 5. Protection elicited by the virus’s M2 protein syncytial is due to CD8+ T cells, while that induced by F and G proteins is due to antibodies. Similar results, with respect to HA and NP proteins, have been obtained in studies with the influenza virus. In some cases, vaccination has a priming effect followed by an anamnestic antibody response, as suggested for the protection of chimpanzees after inoculation with a recombinant vaccinia virus expressing hepatitis B surface antigen. A list of viruses for which protective immune responses have been elicited can be found in a review.

Cusabio Plasmodium falciparum Recombinant

Introduction:

The production of recombinant proteins is essential for the characterization and functional study of Plasmodium falciparum proteins. However, Plasmodium falciparum Recombinant proteins are among the most difficult to express, and when the expression is achieved, recombinant proteins generally misfold leading to inclusion body formation.

Objective:

Obtain and purify four recombinant proteins and use them as antigens to produce polyclonal antibodies. Production efficiency and solubility were evaluated as proteins were expressed in two Escherichia coli strains genetically modified to favour heterologous protein production (BL21-CodonPlus (DE3)-RIL and BL21-pG-KJE8).

Materials and methods:

The four recombinant proteins of P. falciparum correspond to the partial sequences of PfMyoA (Myosin A) and PfGAP50 (slip-associated protein 50) and the complete sequences of PfMTIP (a protein that interacts with the myosin tail). and PfGAP45 (slip-associated protein 45), were produced as glutathione S-transferase fusion proteins, purified and used to immunize mice.

  • Parasites

Parasite strains P. falciparum FCR3S1.2 and TM284S2 were cultured according to standard methods with 10% AB+ Rh+ serum added to the buffered medium (RPMI supplemented with Hepes, gentamicin and sodium bicarbonate). Genomic DNA from these parasites was purified using the EasyDNA purification kit (Invitrogen) according to the manufacturer’s protocol.

  • Recombinant plasmids

Plasmid constructs for expression of the recombinant proteins GST-DBL1α and GST-CIDR1α of FCR3S1.2var 1PfEMP1, GST-DBL1α and GST-DBL2β of TM284S2var 1PfEMP1 were generated as described previously [18, 19].

  • Codon optimization and gene resynthesis

The sequence of the DBL1α domain of FCR3S1.2var 1PfEMP1 was optimized for codon matching in E. coli. Genes were chemically resynthesized (GeneArt, Germany). Resynthesized DBL1α was amplified with oligonucleotide primers (BL-1 5′-ATG GCT ACT TCC GGA GGA, BL-1.1 5′-TTC GAT AAG CAG AAG AAG TAC) and cloned into pGEX4T-1 vector.

  • E. coli strain

The BL21-CodonPlus-RIL strain purchased from Stratagene (California, USA) was used for protein expression. This bacterial strain has been engineered to contain a high copy number of arginine U, leucine W, and isoleucine Y tRNA genes for optimal expression of heterologous proteins from organisms with A/T-rich genetic sequences.

  • Expression of PfEMP1 domains in BL21-CodonPlus-RIL bacteria

Competent BL21 cells were transformed with recombinant pGEX4T-1 plasmids containing FCR3S1.2 DBL1α, TM284S2 DBL1α or TM284S2 DBL2β as inserts. Transformed bacteria were selected on LB agar plates containing ampicillin (100 µg/ml). A single colony of transformed bacteria was inoculated into 30 ml of LB medium containing ampicillin (100 µg/ml) and chloramphenicol (50 µg/ml) for growth at 37°C overnight. Aliquots of the culture were inoculated into one litre of LB medium containing ampicillin (100 µg/ml).

The cultivation was carried out with a stirring speed of 225 rpm. The pH value and the optical density at A600 of the cultures were systematically controlled. Aliquots (50 ml) of each culture were taken sequentially after the OD A600 reached 0.5 and IPTG (isopropyl-b-D-thiogalactopyranoside) was added to a final concentration of 0.1 mM to induce expression. Expression was carried out for three hours at 37°C and the bacteria were subsequently harvested by centrifugation at 4000 rpm for 15 minutes. Recombinant proteins were purified on glutathione-sepharose (Amersham-Pharmacia, Sweden).

  • SDS-PAGE analysis of recombinant proteins

To analyze the recombinant proteins, aliquots of the soluble and insoluble fractions of the expressed proteins from each purification were mixed with an equal volume of SDS-PAGE loading buffer containing β-mercaptoethanol and boiled at 100 °C for 5 min. Denatured proteins were resolved on 10% acrylamide gels containing 1% SDS and visualized by Coomassie brilliant blue solution staining.

  • Binding to heparin and blood group A antigen

Recombinant DBL1α purified from FCR3S1.2 expressed with pGEX plasmids containing the wild-type DBL1 sequence or the codon-optimized sequence was further passed through a HiTrap-heparin column (Amersham-Pharmacia Biotech, Sweden). After washing with PBS tween-20 buffer, bound protein was released from the column with 2M NaCl and immediately dialyzed against cold PBS. Aliquots of the eluted proteins were subjected to SDS-PAGE. The binding of recombinant FCR3S1.2 DBL1α to blood group A antigen was studied using a solid phase assay system.

Results:

Protein expression was much more efficient in BL21-CodonPlus, the strain containing tRNAs that are rare in wild-type E. coli, compared to expression in BL21-pG-KJE8. Although BL21-pG-KJE8 overexpresses chaperones, this strain did not minimize inclusion body formation.

Conclusion:

The use of genetically modified E. coli strains was essential to achieve high levels of expression of the four P. falciparum proteins evaluated and improve the solubility of two of them. The approach used here allowed us to obtain and purify four P. falciparum proteins in sufficient quantity to produce polyclonal antibodies in mice and a good quantity of two pure and soluble recombinant proteins for future tests.

Keywords: Escherichia coli.; Plasmodium falciparum; recombinant proteins.

Cusabio Pongo abelii Recombinant

They are extremely intelligent and have shown evidence of tool use and culture, traits once believed to be uniquely human. Despite being one of our closest relatives, human activities are having a devastating impact on the Sumatran orangutan and its habitat. They are the slowest reproducing of all mammals, with mothers caring for their young for up to 7 years. With such a low reproductive rate, even a small decrease in numbers can lead to extinction.

There are only two species in its genus Pongo abelii Recombinant, the other being the Bornean orangutan. They show more tool use than their sister species from Borneo; compiling a ‘toolbox’ about their lives. Its main threats include the destruction of its lowland rainforest habitat for palm oil plantations and agriculture, logging, the creation of new roads, as well as the death of some by humans or the illegal pet trade. Concerted conservation efforts are needed to prevent this peaceful primate from becoming the first great ape to become extinct in the wild.

Purity: >85% (SDS-PAGE)

Destination Names: PIC

Uniprot No.: Q5RBP8

Alternative Names: PFCs; appropriatedine; P-factor complement

Species: Pongo abelii (Sumatran Orangutan) (Pongo pygmaeus abelii)

Expression Region: 28-469

Protein length: Total length of the mature protein

Label information

The following labels are available.

  • N-terminus His-tagged
  • Without tags
  • The type of label will be determined during the production process. If you have specified a tag type, let us know and we will develop the specified tag preferentially.

Form: Lyophilized powder

Buffer before lyophilization: Tris/PBS based buffer, 6% trehalose, pH 8.0

Reconstitution

We recommend that this vial be briefly centrifuged before opening to bring the contents to the bottom. Reconstitute protein in sterile deionized water at a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and an aliquot for long-term storage at -20℃/-80℃. Our final default glycerol concentration is 50%. Customers could use it for reference.

Storage Conditions

Store at -20°C/-80°C upon receipt, need to be aliquoted for multiple uses. Avoid repeated cycles of freezing and thawing.

Shelf life

Shelf life is related to many factors, storage condition, buffer ingredients, storage temperature and the stability of the protein itself. Generally, the shelf life of the liquid form is 6 months at -20°C/-80°C. The shelf life of the lyophilized form is 12 months at -20°C/-80°C.

Delivery time

The delivery time may differ depending on the way or location of purchase, consult your local distributors for the specific delivery time.

Note: All of our proteins are shipped with regular blue ice packs by default. If you request shipping with dry ice, please contact us in advance and additional fees will be charged.

Notes:

Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.

How are they recognized?

Orangutans are commonly called “red apes” as they have long, soft orange hair. His skin is dark grey. There is a difference in height, which varies from 1.30 m to 1.80 m, but the big difference is in weight, which ranges from 30 to 90 kg. An adult male can be three times as heavy as an adult female.

Orangutans are the largest arboreal animals in the world. As they mainly live high up in the trees, they have developed long arms (up to 2.25m) to help them swing through the forest. Both their feet and hands are incredibly dexterous and they have opposable thumbs like we do, making it easy to pick and peel fruit.

Failure rate in the untreated contralateral node negative neck of small lateralized oral cavity cancers: A multi-institutional collaborative study

Failure rate in the untreated contralateral node negative neck of small lateralized oral cavity cancers: A multi-institutional collaborative study

The significance of treating the bilateral neck in lateralized small oral cavity squamous cell carcinoma (OCC) is unclear. We sought to outline the incidence and predictors of contralateral neck failure (CLF) in sufferers who underwent unilateral remedy. Collaborative high quality consortia can facilitate implementation of high quality measures arising from medical databases. Our statewide basic thoracic surgical procedure (GTS) collaborative investigated the influences of cigarette smoking standing on mortality and main morbidity following lobectomy for lung most cancers.

Society of Thoracic Surgeons General Thoracic Surgery Database information have been recognized from 14 establishments collaborating in a statewide thoracic surgical high quality collaborative between 2012 and 2017. We excluded sufferers with nonelective procedures, stage Zero tumors, American Society of Anesthesiologists class VI illness, and lacking medical traits. Outcomes evaluation included the mixed mortality and main postoperative morbidity charges and the affect of affected person traits, together with smoking standing, on composite rate and on postoperative problems.
The study cohort included 2267 affected person information for evaluation. Overall mixed mortality and main morbidity rate was 10.2% (n = 231). Postoperative 30-day mortality was 1.5%, and main morbidity 9.6%. Significant predictors of the mixed end result included male intercourse (P = .004), physique mass index (P < .001), Zubrod rating (P = .02), smoking pack-years (P = .03), and thoracotomy (P < .001). Higher American Society of Anesthesiologists illness class and superior tumor stage have been marginally related to worse mixed end result (P = .06). Smoking standing; that’s, present, previous (no smoking inside 30 days), or by no means smoked, was not related to worse mixed end result (P = .56) and had no vital affect on main problems.
Smoking standing was not related to worse outcomes; nonetheless, smoking dose (pack-years) was related to worse mixed mortality and main morbidity. A statewide high quality collaborative supplies constructive suggestions for collaborating establishments and surgeons, selling high quality enchancment in perioperative affected person care methods and improved outcomes.

We carried out a multi-institutional retrospective study of sufferers with pathologic T1-T2 (AJCC seventh version) OCC with clinically node negative contralateral neck who underwent unilateral remedy with main surgical resection ± adjuvant radiotherapy between 2005 and 2015. Incidence of CLF was estimated utilizing the cumulative incidence methodology. Clinicopathological components have been analyzed by univariate (UVA) and multivariate evaluation (MVA) for attainable affiliation with CLF. Kaplan-Meier evaluation was used to estimate total survival (OS).

Failure rate in the untreated contralateral node negative neck of small lateralized oral cavity cancers: A multi-institutional collaborative study

The subsequent era of collaborative care: The design of a novel web-based stepped collaborative care intervention delivered by way of telemedicine for individuals identified with most cancers

The NIH consensus assertion on cancer-related signs concluded the most typical and debilitating have been despair, ache and fatigue (American Cancer Society, 2019; Qaseem et al., 2008; Meijer et al., 2013; Meijer, 2011 [1-6]). Although the comorbidity of these signs is well-known and will have related underlying organic mechanisms; but no intervention has been developed to scale back these signs concurrently. The novel web-based stepped collaborative care intervention delivered by telemedicine is the first to be examined in individuals identified with most cancers.
We plan to check a web-based stepped collaborative care intervention with 450 most cancers sufferers and 200 caregivers in the context of a randomized managed trial. The main outcomes embrace the evaluation of patient-reported despair, ache, fatigue and high quality of life. Secondary end result embrace affected person serum ranges of pro-inflammatory cytokines and illness development. We additionally will assess casual caregiver stress, despair, and metabolic syndrome to find out if enhancements in sufferers’ signs additionally outcome in enchancment in caregiver outcomes.
The trial is ongoing and a complete of 370 affected person have been randomized. Preliminary analyses of the screening instruments used for study entry recommend that Center for Epidemiological Studies-Depression (CESD) scale has good sensitivity and specificity (0.77 and 0.85) whereas the scale used to evaluate ache (0.47 and 0.91) and fatigue (0.11 and 0.91) had poor sensitivity however glorious specificity. Using the AUROC, the finest minimize level for the CES-D was 15.5, for ache was 4.5; and for fatigue was 2.5. Outcomes not initially proposed included well being care utilization and healthcare fees. For the first 100 sufferers who’ve been adopted a yr post-treatment, and who have been lower than 75 years and randomized to the web-based stepped collaborative care intervention, had decrease charges of problems after surgical procedure [χ2 = 5.45, p = 0.02].
For sufferers who survived 6 months or much less and have been randomized to the web-based stepped collaborative care intervention, had decrease charges of 90-day readmissions when in comparison with sufferers randomized to the screening and referral arm [χ2 = 4.0, p = 0.046]. Patients randomized to the collaborative care intervention arm had decrease imply total well being care fees of $19,546 per affected person per yr when in comparison with the screening and referral arm.

Rat Aβ1-42 ELISA Kit

ERA0919 96Tests
EUR 521

Rabbit Aβ1-42 ELISA Kit

ERTA0919 96Tests
EUR 521

Anserini Aβ1-42 ELISA Kit

EAA0919 96Tests
EUR 521

Goat Aβ1-42 ELISA Kit

EGTA0919 96Tests
EUR 521

Canine Aβ1-42 ELISA Kit

ECA0919 96Tests
EUR 521

Bovine Aβ1-42 ELISA Kit

EBA0919 96Tests
EUR 521

Guinea Pig Aβ1-42 ELISA Kit

EGA0919 96Tests
EUR 521

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA Kit

CN-02503M1 96T
EUR 457

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA Kit

CN-02503M2 48T
EUR 306

Mouse amyloid beta peptide 1-42(Aβ1-42)ELISA Kit

GA-E0181MS-48T 48T
EUR 336

Mouse amyloid beta peptide 1-42(Aβ1-42)ELISA Kit

GA-E0181MS-96T 96T
EUR 534

Mouse amyloid beta peptide 1-42(Aβ1-42)ELISA Kit

QY-E20081 96T
EUR 361

amyloid-β,Aβ1-42

E62B010 20ug
EUR 382

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA Kit

CN-01630R1 96T
EUR 457

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA Kit

CN-01630R2 48T
EUR 306

Porcine amyloid beta peptide 1-42,Aβ1-42 ELISA Kit

GA-E0087PC-48T 48T
EUR 364

Porcine amyloid beta peptide 1-42,Aβ1-42 ELISA Kit

GA-E0087PC-96T 96T
EUR 590

Rat amyloid beta peptide 1-42(Aβ1-42)ELISA Kit

GA-E0102RT-48T 48T
EUR 336

Rat amyloid beta peptide 1-42(Aβ1-42)ELISA Kit

GA-E0102RT-96T 96T
EUR 534

Rat amyloid beta peptide 1-42(Aβ1-42)ELISA Kit

QY-E11551 96T
EUR 361

Human amyloid beta peptide 1-42,Aβ1-42 ELISA Kit 96T

CN-03717H1 96T
EUR 461

Human amyloid beta peptide 1-42,Aβ1-42 ELISA Kit 96T

CN-03717H2 48T
EUR 310

Human amyloid beta peptide 1-42(Aβ1-42)ELISA Kit 96T

GA-E1281HM-48T 48T
EUR 289

Human amyloid beta peptide 1-42(Aβ1-42)ELISA Kit 96T

GA-E1281HM-96T 96T
EUR 466

Human amyloid beta peptide 1-42(Aβ1-42)ELISA Kit 96T

QY-E04413 96T
EUR 361

Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

DLR-Ab1-42-Mu-48T 48T
EUR 489
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse Amyloid Beta Peptide 1-42 (Ab1-42) in samples from serum, plasma or other biological fluids.

Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

DLR-Ab1-42-Mu-96T 96T
EUR 635
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse Amyloid Beta Peptide 1-42 (Ab1-42) in samples from serum, plasma or other biological fluids.

Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

RD-Ab1-42-Mu-48Tests 48 Tests
EUR 489

Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

RD-Ab1-42-Mu-96Tests 96 Tests
EUR 677

Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

RDR-Ab1-42-Mu-48Tests 48 Tests
EUR 511

Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

RDR-Ab1-42-Mu-96Tests 96 Tests
EUR 709

Human Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

DLR-Ab1-42-Hu-48T 48T
EUR 479
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human Amyloid Beta Peptide 1-42 (Ab1-42) in samples from serum, plasma or other biological fluids.

Human Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

DLR-Ab1-42-Hu-96T 96T
EUR 621
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human Amyloid Beta Peptide 1-42 (Ab1-42) in samples from serum, plasma or other biological fluids.

Rat Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

DLR-Ab1-42-Ra-48T 48T
EUR 508
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat Amyloid Beta Peptide 1-42 (Ab1-42) in samples from serum, plasma or other biological fluids.

Rat Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

DLR-Ab1-42-Ra-96T 96T
EUR 661
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat Amyloid Beta Peptide 1-42 (Ab1-42) in samples from serum, plasma or other biological fluids.

Human Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

RD-Ab1-42-Hu-48Tests 48 Tests
EUR 478

Human Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

RD-Ab1-42-Hu-96Tests 96 Tests
EUR 662

Rat Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

RD-Ab1-42-Ra-48Tests 48 Tests
EUR 511

Rat Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

RD-Ab1-42-Ra-96Tests 96 Tests
EUR 709

Human Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

RDR-Ab1-42-Hu-48Tests 48 Tests
EUR 500

Human Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

RDR-Ab1-42-Hu-96Tests 96 Tests
EUR 692

Rat Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

RDR-Ab1-42-Ra-48Tests 48 Tests
EUR 534

Rat Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

RDR-Ab1-42-Ra-96Tests 96 Tests
EUR 742

Mouse Aβ1-40 ELISA Kit

EMA0917 96Tests
EUR 521

Porcine Aβ1-40 ELISA Kit

EPA0917 96Tests
EUR 521

Rat Aβ1-40 ELISA Kit

ERA0917 96Tests
EUR 521

Rabbit Aβ1-40 ELISA Kit

ERTA0917 96Tests
EUR 521

Anserini Aβ1-40 ELISA Kit

EAA0917 96Tests
EUR 521

Goat Aβ1-40 ELISA Kit

EGTA0917 96Tests
EUR 521

Canine Aβ1-40 ELISA Kit

ECA0917 96Tests
EUR 521

Bovine Aβ1-40 ELISA Kit

EBA0917 96Tests
EUR 521

Cpn (Chlamydia Pneumoniae Antibody IgG) ELISA test

42 96T/Box Ask for price
Description: ELISA based test for quantitative detection of Cpn (Chlamydia Pneumoniae Antibody IgG)

Guinea Pig Aβ1-40 ELISA Kit

EGA0917 96Tests
EUR 521

Mouse beta-42(Amyloid Beta 1-42) ELISA Kit

STJ150004 1 kit
EUR 412
Description: The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of Abeta1-42 in Mouse serum, plasma and other biological fluids

Custom Antibody titration by ELISA up to 2 rabbits and 1 bleed

ELISA-1 1
EUR 202

Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Mu-10x96wellstestplate 10x96-wells test plate
EUR 4391.16
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Mouse Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Mu-1x48wellstestplate 1x48-wells test plate
EUR 449.27
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Mouse Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Mu-1x96wellstestplate 1x96-wells test plate
EUR 598.96
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Mouse Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Mu-5x96wellstestplate 5x96-wells test plate
EUR 2395.32
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Mouse Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

4-CEA946Mu
  • EUR 4442.00
  • EUR 2346.00
  • EUR 599.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Mouse Amyloid Beta Peptide 1-42 (Ab1-42) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species.

Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

20-abx153578
  • EUR 6642.00
  • EUR 3542.00
  • EUR 825.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

abx255206-96tests 96 tests
EUR 668

Mouse Amyloid Beta Peptide 1-42 ELISA Kit (Ab1-42)

RK02559 96 Tests
EUR 521

Mouse amyloid beta peptide 1-40,Aβ1-40 ELISA Kit

CN-02744M1 96T
EUR 461

Mouse amyloid beta peptide 1-40,Aβ1-40 ELISA Kit

CN-02744M2 48T
EUR 310

Mouse amyloid beta peptide 1-40(Aβ1-40)ELISA Kit

GA-E0318MS-48T 48T
EUR 336

Mouse amyloid beta peptide 1-40(Aβ1-40)ELISA Kit

GA-E0318MS-96T 96T
EUR 534

Mouse amyloid beta peptide 1-40(Aβ1-40)ELISA Kit

QY-E20080 96T
EUR 361

Mouse amyloid beta peptide 1-42, Aβ1-42 ELISA Kit

CSB-E10787m-24T 1 plate of 24 wells
EUR 165
Description: Quantitativesandwich ELISA kit for measuring Mouse amyloid beta peptide 1-42, Aβ1-42 in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Mouse amyloid beta peptide 1-42, Aβ1-42 ELISA Kit

1-CSB-E10787m
  • EUR 946.00
  • EUR 5782.00
  • EUR 3060.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Mouse amyloid beta peptide 1-42, Aβ1-42 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

ELISA kit for Mouse Ab1-42 (Amyloid Beta Peptide 1-42)

ELK4915 1 plate of 96 wells
EUR 432
Description: A competitive Inhibition ELISA kit for detection of Amyloid Beta Peptide 1-42 from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

ELISA kit for Mouse A?1-42 (Amyloid Beta 1-42)

E-EL-M0068 1 plate of 96 wells
EUR 377
Description: A sandwich ELISA kit for quantitative measurement of Mouse A?1-42 (Amyloid Beta 1-42) in samples from Serum, Plasma, Cell supernatant

Mouse Transmembrane protein 42, Tmem42 ELISA KIT

ELI-51821m 96 Tests
EUR 865

Mouse Amyloid β Protein 42 ELISA kit

E03A0050-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Mouse Amyloid β Protein 42 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Amyloid β Protein 42 ELISA kit

E03A0050-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Mouse Amyloid β Protein 42 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Amyloid β Protein 42 ELISA kit

E03A0050-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Mouse Amyloid β Protein 42 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Serine protease 42, Prss42 ELISA KIT

ELI-35923m 96 Tests
EUR 865

Mouse Aβ42(Amyloid Beta 42) ELISA Kit

EM0864 96T
EUR 476.25
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 2.344pg/ml

Wide-range Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

WEA946Mu-10x96wellstestplate 10x96-wells test plate
EUR 4181.72
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Wide-range Mouse Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Wide-range Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

WEA946Mu-1x48wellstestplate 1x48-wells test plate
EUR 432.02
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Wide-range Mouse Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Wide-range Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

WEA946Mu-1x96wellstestplate 1x96-wells test plate
EUR 574.32
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Wide-range Mouse Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Wide-range Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

WEA946Mu-5x96wellstestplate 5x96-wells test plate
EUR 2284.44
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Wide-range Mouse Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Wide-range Mouse Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

4-WEA946Mu
  • EUR 4232.00
  • EUR 2235.00
  • EUR 575.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Wide-range Mouse Amyloid Beta Peptide 1-42 (Ab1-42) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species.

Mouse Wide-range Amyloid Beta Peptide 1-42 ELISA Kit (Ab1-42)

RK02560 96 Tests
EUR 521

Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

20-abx258778
  • EUR 7378.00
  • EUR 3933.00
  • EUR 911.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Rat beta-42(Amyloid Beta 1-42) ELISA Kit

STJ150196 1 kit
EUR 412
Description: The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of Abeta1-42 in Rat serum, plasma and other biological fluids

Mouse Amyloid Beta Peptide 1-42 (Ab1-42) CLIA Kit

20-abx490328
  • EUR 7973.00
  • EUR 4246.00
  • EUR 981.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human amyloidβ1-42 ELISA Kit

EHA0919 96Tests
EUR 521

TMB ELISA Substrate

42-TB08 100 ml
EUR 122
Description: High sensitivity HRP microwell substrate (containing TMB)

AR-42 (HDAC-42)

2716-1
EUR 153

AR-42 (HDAC-42)

2716-5
EUR 457

Human Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Hu-10x96wellstestplate 10x96-wells test plate
EUR 4273.35
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Human Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Human Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Hu-1x48wellstestplate 1x48-wells test plate
EUR 439.57
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Human Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Human Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Hu-1x96wellstestplate 1x96-wells test plate
EUR 585.1
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Human Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Human Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Hu-5x96wellstestplate 5x96-wells test plate
EUR 2332.95
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Human Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Human Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

4-CEA946Hu
  • EUR 4324.00
  • EUR 2283.00
  • EUR 586.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Human Amyloid Beta Peptide 1-42 (Ab1-42) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species.

Rat Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Ra-10x96wellstestplate 10x96-wells test plate
EUR 4626.78
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Rat Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Rat Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Ra-1x48wellstestplate 1x48-wells test plate
EUR 468.68
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Rat Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Rat Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Ra-1x96wellstestplate 1x96-wells test plate
EUR 626.68
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Rat Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Rat Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Ra-5x96wellstestplate 5x96-wells test plate
EUR 2520.06
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Rat Amyloid Beta Peptide 1-42 (Ab1-42) in serum, plasma and other biological fluids.

Rat Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

4-CEA946Ra
  • EUR 4677.00
  • EUR 2471.00
  • EUR 627.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Rat Amyloid Beta Peptide 1-42 (Ab1-42) in samples from Serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species.

Human Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

20-abx574166
  • EUR 6642.00
  • EUR 3542.00
  • EUR 825.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Rat Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

20-abx574490
  • EUR 7237.00
  • EUR 3855.00
  • EUR 895.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

abx053399-96tests 96 tests
EUR 668

Rat Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

abx256724-96tests 96 tests
EUR 668

Pig Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

abx361616-96tests 96 tests
EUR 825

Rabbit Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

abx362133-96tests 96 tests
EUR 825

Sheep Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

abx364753-96tests 96 tests
EUR 926

Monkey Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

abx353385-96tests 96 tests
EUR 825

Chicken Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

abx357107-96tests 96 tests
EUR 825

Human beta-42(Amyloid Beta Peptide 1-42) ELISA Kit

STJ150128 1 kit
EUR 412
Description: The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of Abeta1-42 in human serum, plasma and other biological fluids

Rat Amyloid Beta Peptide 1-42 ELISA Kit (Ab1-42)

RK03456 96 Tests
EUR 521

Human Amyloid Beta Peptide 1-42 ELISA Kit (Ab1-42)

RK00785 96 Tests
EUR 521

Mouse RNA- binding protein 42, Rbm42 ELISA KIT

ELI-30075m 96 Tests
EUR 865

Mouse Zinc finger protein 42, Zfp42 ELISA KIT

ELI-40323m 96 Tests
EUR 865

Mouse Cell Division Cycle 42 (CDC42) ELISA Kit

abx512594-96tests 96 tests
EUR 668

ELISA kit for Mouse Beta-amyloid protein 42

EK2842 96 tests
EUR 553
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse Beta-amyloid protein 42 in samples from serum, plasma, tissue homogenates and other biological fluids.

Frit Kit

FRIT-KIT 1each
EUR 124
Description: Kit to create frits in capillaries. Includes formamide, Kasil-1, Kasil-1624 and a cleaving tool.

Column Packing Kit

PACK-KIT 1pack
EUR 1035
Description: Column packing kit for pressure cells. Includes: HPREG regulator, TBNG10 tubing, CAP-75 capillary, and STRB5X2 stir bar.

Rat amyloid beta peptide 1- 42, ABeta 1- 42 ELISA KIT

ELA-E0946r 96 Tests
EUR 886

Multi-species Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Mi-10x96wellstestplate 10x96-wells test plate
EUR 4810.04
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Multi-species Amyloid Beta Peptide 1-42 (Ab1-42).

Multi-species Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Mi-1x48wellstestplate 1x48-wells test plate
EUR 483.77
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Multi-species Amyloid Beta Peptide 1-42 (Ab1-42).

Multi-species Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Mi-1x96wellstestplate 1x96-wells test plate
EUR 648.24
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Multi-species Amyloid Beta Peptide 1-42 (Ab1-42).

Multi-species Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

CEA946Mi-5x96wellstestplate 5x96-wells test plate
EUR 2617.08
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Multi-species Amyloid Beta Peptide 1-42 (Ab1-42).

Multi-species Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

4-CEA946Mi
  • EUR 4861.00
  • EUR 2568.00
  • EUR 649.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Multi-species Amyloid Beta Peptide 1-42 (Ab1-42) in samples from n/a with no significant corss-reactivity with analogues from other species.

Monkey amyloid beta peptide 1-42, Aβ1-42 ELISA Kit

CSB-E14398Mk-24T 1 plate of 24 wells
EUR 165
Description: Quantitativesandwich ELISA kit for measuring Monkey amyloid beta peptide 1-42, Aβ1-42 in samples from serum, plasma. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Monkey amyloid beta peptide 1-42, Aβ1-42 ELISA Kit

1-CSB-E14398Mk
  • EUR 900.00
  • EUR 5476.00
  • EUR 2900.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Monkey amyloid beta peptide 1-42, Aβ1-42 in samples from serum, plasma. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Human amyloid beta peptide 1-42, Aβ1-42 ELISA Kit

CSB-E10684h-24T 1 plate of 24 wells
EUR 165
Description: Quantitativesandwich ELISA kit for measuring Human amyloid beta peptide 1-42, Aβ1-42 in samples from serum, plasma, tissue homogenates, cerebrospinalfluid (CSF). A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human amyloid beta peptide 1-42, Aβ1-42 ELISA Kit

1-CSB-E10684h
  • EUR 900.00
  • EUR 5476.00
  • EUR 2900.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Human amyloid beta peptide 1-42, Aβ1-42 in samples from serum, plasma, tissue homogenates, cerebrospinalfluid(CSF). Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Rat amyloid beta peptide 1-42, Aβ1-42 ELISA Kit

CSB-E10786r-24T 1 plate of 24 wells
EUR 165
Description: Quantitativesandwich ELISA kit for measuring Rat amyloid beta peptide 1-42, Aβ1-42 in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Rat amyloid beta peptide 1-42, Aβ1-42 ELISA Kit

1-CSB-E10786r
  • EUR 967.00
  • EUR 5925.00
  • EUR 3134.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Rat amyloid beta peptide 1-42, Aβ1-42 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

ELISA kit for Monkey A?1-42 (Amyloid Beta 1-42)

E-EL-MK1824 1 plate of 96 wells
EUR 584
Description: A sandwich ELISA kit for quantitative measurement of Monkey A?1-42 (Amyloid Beta 1-42) in samples from Serum, Plasma, Cell supernatant

ELISA kit for Rat A?1-42 (Amyloid Beta 1-42)

E-EL-R1402 1 plate of 96 wells
EUR 377
Description: A sandwich ELISA kit for quantitative measurement of Rat A?1-42 (Amyloid Beta 1-42) in samples from Serum, Plasma, Cell supernatant

ELISA kit for Human Ab1-42 (Amyloid Beta Peptide 1-42)

ELK2100 1 plate of 96 wells
EUR 432
Description: A competitive Inhibition ELISA kit for detection of Amyloid Beta Peptide 1-42 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

ELISA kit for Human A?1-42 (Amyloid Beta 1-42)

E-EL-H0543 1 plate of 96 wells
EUR 377
Description: A sandwich ELISA kit for quantitative measurement of Human A?1-42 (Amyloid Beta 1-42) in samples from Serum, Plasma, Cell supernatant

ELISA kit for Rat Ab1-42 (Amyloid Beta Peptide 1-42)

ELK4897 1 plate of 96 wells
EUR 432
Description: A competitive Inhibition ELISA kit for detection of Amyloid Beta Peptide 1-42 from Rat in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Guinea pig Amyloid Beta Peptide 1-42 (Ab1-42) ELISA Kit

abx358014-96tests 96 tests
EUR 825

Rabbit amyloid beta peptide 1-40,Aβ1-40 ELISA Kit

CN-00638R1 96T
EUR 481

Rabbit amyloid beta peptide 1-40,Aβ1-40 ELISA Kit

CN-00638R2 48T
EUR 332

Rat amyloid beta peptide 1-40,Aβ1-40 ELISA Kit

CN-01866R1 96T
EUR 494

Rat amyloid beta peptide 1-40,Aβ1-41 ELISA Kit

CN-01866R2 48T
EUR 344

Human amyloid beta peptide 1-40,Aβ1-40 ELISA Kit

CN-03356H1 96T
EUR 454

Human amyloid beta peptide 1-40,Aβ1-40 ELISA Kit

CN-03356H2 48T
EUR 303

Horse amyloid beta peptide 1-40,Aβ1-40 ELISA Kit

CN-05164H1 96T
EUR 464

Horse amyloid beta peptide 1-40,Aβ1-41 ELISA Kit

CN-05164H2 48T
EUR 313

Rabbit amyloid beta peptide 1-40,Aβ1-40 ELISA Kit

GA-E0029RB-48T 48T
EUR 326

Rabbit amyloid beta peptide 1-40,Aβ1-40 ELISA Kit

GA-E0029RB-96T 96T
EUR 524

Porcine amyloid beta peptide 1-40,Aβ1-40 ELISA Kit

GA-E0086PC-48T 48T
EUR 364

Porcine amyloid beta peptide 1-40,Aβ1-40 ELISA Kit

GA-E0086PC-96T 96T
EUR 590

Rat amyloid beta peptide 1-40(Aβ1-40)ELISA Kit

GA-E0101RT-48T 48T
EUR 317

Rat amyloid beta peptide 1-40(Aβ1-40)ELISA Kit

GA-E0101RT-96T 96T
EUR 496

Human amyloid beta peptide 1-40(Aβ1-40)ELISA Kit

GA-E1247HM-48T 48T
EUR 289

Human amyloid beta peptide 1-40(Aβ1-40)ELISA Kit

GA-E1247HM-96T 96T
EUR 466

Human amyloid beta peptide 1-40(Aβ1-40)ELISA Kit

QY-E04414 96T
EUR 361

Rat amyloid beta peptide 1-40(Aβ1-40)ELISA Kit

QY-E11552 96T
EUR 361

Equine amyloid beta peptide 1-40,Aβ1-40 ELISA Kit

QY-E120008 96T
EUR 478

PCR Mycoplasma Detection Kit

M034-Kit Kit
EUR 266

Amyloid Beta 42 (Human) ELISA Kit

E4288-100
EUR 805

A尾42 ELISA KIT|Human

EF001936 96 Tests
EUR 689

Human β Amyloid 42 ELISA Kit

DEIA1127 96T
EUR 2235
Description: The Human β Amyloid 42 ELISA kit is designed to detect and quantify the level of human β Amyloid 42 in urine.
In a separate analyses centered on the caregivers, we discovered that after adjusting for age, gender, and race; low ranges of caregiver high quality of life (HR = 1.067, 95% CI = 1.019-1.117, p = 0.006), excessive ranges of hostility (HR = 1.142, 95% CI = 1.030-1.267, p = 0.012), and alcohol use (HR = 4.193, 95% CI = 1.174-14.978, p = 0.027) have been vital predictors of metabolic syndrome. The NCI-MATCH is a nationwide grasp protocol trial, printed in the Journal of Clinical Oncology, in which numerous tumors are sequenced and sufferers assigned to remedy. The trial demonstrates the feasibility of figuring out uncommon and customary actionable genetic alterations and underscores the power of educational/neighborhood partnerships for bettering trial entry.

A cluster randomized controlled trial comparing Virtual Learning Collaborative and Technical Assistance strategies to implement an early palliative care program for patients with advanced cancer and their caregivers: a study protocol

A cluster randomized controlled trial comparing Virtual Learning Collaborative and Technical Assistance strategies to implement an early palliative care program for patients with advanced cancer and their caregivers: a study protocol
Virtual Learning Collaboratives (VLC), studying communities centered on a widespread objective, are used incessantly in healthcare settings to implement finest practices. Yet, there may be restricted analysis testing the effectiveness of this strategy in contrast to different implementation strategies. This study evaluates the effectiveness of a VLC in contrast to Technical Assistance (TA) amongst neighborhood oncology practices implementing ENABLE (Educate, Nurture, Advise, Before Life Ends), an evidence-based, early palliative care telehealth, psycho-educational intervention for patients with newly identified advanced cancer and their caregivers.
 Using Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) and Proctor’s Implementation Outcomes Frameworks, this two-arm hybrid type-III cluster-randomized controlled trial (RCT) will evaluate two implementation strategies, VLC versus TA, among the many 48 National Cancer Institute Community Oncology Research Program (NCORP) observe clusters that haven’t traditionally supplied palliative care to all patients with advanced cancer. Three cohorts of observe clusters shall be randomized to the study arms. Each observe cluster will recruit 15-27 patients and a household caregiver to take part in ENABLE.
The main study consequence is ENABLE uptake (affected person degree), i.e., the proportion of eligible patients who full the ENABLE program (obtain a palliative care evaluation and full the six ENABLE classes over 12 weeks). The secondary consequence is general program implementation (observe cluster degree), as measured by the General Organizational Index at baseline, 6, and 12 months. Exploratory goals assess affected person and caregiver temper and high quality of life outcomes at baseline, 12, and 24 weeks. Practice cluster randomization will search to maintain the proportion of rural practices, observe sizes, and minority patients seen inside every observe
This study will advance the sphere of implementation science by evaluating VLC effectiveness, a generally used however understudied, implementation technique. The study will advance the sphere of palliative care by constructing the capability and infrastructure to implement an early palliative care program in neighborhood oncology practices. The LARS rating is an internationally well-accepted questionnaire to assess low anterior resection syndrome, however at the moment there isn’t any formally validated Italian model.
The English model of the LARS rating was translated into Italian following the forward-and-back translation course of. A whole of 147 patients crammed out our model. Among them, 40 patients answered the questionnaire twice for the test-retest reliability part. The validity of the LARS rating was examined utilizing convergent and discriminant validity indicators by correlating the EORTC QLQ-C30 and QLQ-CR29 questionnaires. The LARS rating functionality to differentiate teams of patients with totally different demographic or medical options was additionally assessed.

Performance Characteristics of the Ultrasound Strategy throughout Incidence Screening within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

Randomised controlled trials of ovarian cancer (OC) screening haven’t but demonstrated an affect on illness mortality. Meanwhile, the screening information from medical trials represents a wealthy useful resource to perceive the efficiency of modalities used. We report right here on incidence screening within the ultrasound arm of UKCTOCS. 44,799 of the 50,639 girls who had been randomised to annual screening with transvaginal ultrasound attended annual incidence screening between 28 April 2002 and 31 December 2011. Transvaginal ultrasound was used each as the primary and the second line check. Participants had been adopted up by way of digital well being report linkage and postal questionnaires.

Out of 280,534 annual incidence screens, 960 girls underwent screen-positive surgical procedure. 113 had ovarian/tubal cancer (80 invasive epithelial). Of the screen-detected invasive epithelial cancers, 37.5% (95% CI: 26.9-49.0) had been Stage I/II. An extra 52 (50 invasive epithelial) had been identified inside one yr of their final display screen. Of the 50 interval epithelial cancers, 6.0% (95% CI: 1.3-16.5) had been Stage I/II. For detection of all ovarian/tubal cancers identified inside one yr of display screen, the sensitivity, specificity, and optimistic predictive values had been 68.5% (95% CI: 60.8-75.5), 99.7% (95% CI: 99.7-99.7), and 11.8% (95% CI: 9.8-14) respectively.

When the evaluation was restricted to invasive epithelial cancers, sensitivity, specificity and optimistic predictive values had been 61.5% (95% CI: 52.6-69.9); 99.7% (95% CI: 99.7-99.7) and 8.3% (95% CI: 6.7-10.3), with 12 surgical procedures per display screen optimistic. The low sensitivity coupled with the advanced stage of interval cancers means that ultrasound scanning as the primary line check may not be appropriate for inhabitants screening for ovarian cancer. Trial registration: ISRCTN22488978. Registered on 6 April 2000.

A cluster randomized controlled trial comparing Virtual Learning Collaborative and Technical Assistance strategies to implement an early palliative care program for patients with advanced cancer and their caregivers: a study protocol

The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer

Well-annotated, high-quality biorepositories present a priceless platform to assist translational analysis. However, most biorepositories have poor illustration of minority teams, limiting the power to deal with well being disparities. Methods: We describe the institution of the Florida Pancreas Collaborative (FPC), the primary state-wide potential cohort study and biorepository designed to deal with the upper burden of pancreatic cancer (PaCa) in African Americans (AA) in contrast to Non-Hispanic Whites (NHW) and Hispanic/Latinx (H/L).

We present an overview of stakeholders; study eligibility and design; recruitment strategies; customary working procedures to accumulate, course of, retailer, and switch biospecimens, medical photographs, and information; our cloud-based information administration platform; and progress relating to recruitment and biobanking. Results: The FPC consists of multidisciplinary groups from fifteen Florida medical establishments.

USP45 Rabbit pAb

A5074-200ul 200 ul
EUR 459

USP45 Rabbit pAb

A5074-20ul 20 ul Ask for price

USP45 Rabbit pAb

A5074-50ul 50 ul Ask for price

USP45 Antibody

ABD4595 100 ug
EUR 438

USP45 antibody

70R-21212 50 ul
EUR 435
Description: Rabbit polyclonal USP45 antibody

USP45 Antibody

DF4595 200ul
EUR 304
Description: USP45 Antibody detects endogenous levels of total USP45.

USP45 Antibody

1-CSB-PA741097LA01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against USP45. Recognizes USP45 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

USP45 Antibody

CSB-PA226027-
EUR 335
Description: A polyclonal antibody against USP45. Recognizes USP45 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

USP45 Antibody

CSB-PA226027-100ul 100ul
EUR 316
Description: A polyclonal antibody against USP45. Recognizes USP45 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

USP45 Antibody

1-CSB-PA693911
  • EUR 317.00
  • EUR 244.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against USP45. Recognizes USP45 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100

USP45 Antibody

1-CSB-PA070065
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against USP45. Recognizes USP45 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000

USP45 Antibody

1-CSB-PA025737GA01HU
  • EUR 597.00
  • EUR 333.00
  • 150ul
  • 50ul
Description: A polyclonal antibody against USP45. Recognizes USP45 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

USP45 Antibody

1-CSB-PA797784
  • EUR 317.00
  • EUR 244.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against USP45. Recognizes USP45 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100

USP45 Antibody

35125-100ul 100ul
EUR 252

USP45 Antibody

35125-50ul 50ul
EUR 187

USP45 Antibody

42822-100ul 100ul
EUR 252

Anti-USP45 antibody

PAab09335 100 ug
EUR 386

Anti-USP45 Antibody

A09878 100ul
EUR 397
Description: Rabbit Polyclonal USP45 Antibody. Validated in WB and tested in Human.

Anti-USP45 antibody

STJ27068 100 µl
EUR 277
Description: The protein encoded by this gene is a deubiquitylase that binds ERCC1, the catalytic subunit of the XPF-ERCC1 DNA repair endonuclease. This endonuclease is a critical regulator of DNA repair processes, and the deubiquitylase activity of the encoded protein is important for maintaining the DNA repair ability of XPF-ERCC1.

Anti-USP45 antibody

STJ96207 200 µl
EUR 197
Description: Rabbit polyclonal to USP45.

USP45 Conjugated Antibody

C42822